Systems offer both value and advantages, but choosing the right partner is crucial for success.
December 1st @9am CST
The world’s population is aging, and rapidly. By 2050, it is projected that the proportion of people aged 65 and older will be more than double that of children aged 5. This development is occurring primarily in Europe, however, some Asian and Latin American countries are quickly ‘catching up.’
This global phenomenon is also leading to an increasing number of people suffering from chronic diseases such as diabetes and osteoporosis. Combined, these trends are making it difficult for health care professionals to effectively treat patients over the long term. Thus, increased attention is leading to a growth in patient-friendly administration systems such as single-and dual-chamber cartridges in combination with a pen device.
The decision to develop a drug product in a cartridge-pen combination will depend on specific drug and market characteristics. This is why cartridges require complex end-to-end solutions for both filling and assembly. Vetter experts Joerg Zimmermann and Kevin J. Wrigley will discuss these challenges and how to choose the right CDMO when developing a drug product in a pen cartridge combination. They will also examine the advantages of these devices and how they can add value to a compound.
By attending this webinar the participant will:
- Gain an understanding of why the demographic changes and an aging population have increased the need for patient-and-administration-friendly injection systems.
- Learn how cartridges can offer distinct advantages, especially in life cycle management strategies.
- Through a case study, gain an appreciation for the challenges in filling and assembling this injection system.
- Understand what must be considered when choosing the right partner for aseptic filling and packaging solutions.
This webinar will run twice at the following times:
10AM New York / 9AM Chicago
This webinar is sponsored by Vetter.